Ibrutinib and rituximab induced rapid response in refractory Richter syndrome. Issue 7 (5th June 2015)

• Record Type: Journal Article
• Authors: Lamar, Zanetta; Kennedy, LeAnne; Kennedy, Brooke; Lynch, Mary; Goad, Amanda; Hurd, David; McIver, Zachariah
• Is Part Of: Clinical case reports. Volume 3:Issue 7(2015:Jul.)
• Page Start: 615
• Page End: 617
• Publication Date: 2015-06-05
• Subjects: Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.269
• Languages: English
• ISSNs: 2050-0904

Abstract

<abstract abstract-type="main" id="ccr3269-abs-0001"> <title>Key Clinical Message</title> <p>We report a 53‐year‐old man diagnosed with Richter syndrome. He was heavily pretreated and was refractory to prior therapy. He received rituximab and ibrutinib, and achieved a significant response after 1 month of therapy. Our case illustrates the importance of investigation of rituximab and ibrutinib in Richter's syndrome.</p> </abstract>